[Phosphodiesterase inhibition as a new positive-inotropic principle].
D015082:2,2'-Dipyridyl / Q000627:therapeutic use; D000818:Animals; D001562:Benzimidazoles / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D009200:Myocardial Contraction / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D010793:Phthalazines / Q000627:therapeutic use; D011724:Pyridazines / Q000627:therapeutic use; D013268:Stimulation, Chemical
D001562:Benzimidazoles; D002316:Cardiotonic Agents; D007093:Imidazoles; D010726:Phosphodiesterase Inhibitors; D010793:Phthalazines; D011724:Pyridazines; D015082:2,2'-Dipyridyl; C042527:imazodan
Phosphodiesterasehemmung als neues positiv-inotropes Prinzip.